Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathan M Lancaster

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2003
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North CarolinaJohnathan M Lancaster, Robert M Wenham, Susan Halabi, et al.
The Journal of Biological Chemistry|September 15, 2011
Fascin protein is critical for transforming growth factor β protein-induced invasion and filopodia formation in spindle-shaped tumor cellsJianwei Sun, Huifang He, Yin Xiong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2012
Preoperative enoxaparin is safe to use in major gynecologic surgery for prophylaxis of venous thromboembolism: a retrospective cohort studyMartin A Martino, Jennifer G George, Christine C Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2021
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody DisordersDavid Stein, Ernesto Oviedo-Orta, Wendy A Kampman, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2002
Cell proliferation and apoptosis in human uterine leiomyomas and myometriaDarlene Dixon, Gordon P Flake, Alicia B Moore, et al.
Gynecologic Oncology|December 31, 2002
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancerLaura J Havrilesky, Angeles A Alvarez, Robyn A Sayer, et al.
Annals of Surgical Oncology|January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast CancerHatem Soliman, Susanne Wagner, Darl D Flake, et al.
Gynecologic Oncology|October 24, 2007
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M Lancaster, C Bethan Powell, Noah D Kauff, et al.
Gynecologic Oncology|April 30, 2013
A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapyRobert M Wenham, James Lapolla, Hui-Yi Lin, et al.
The Journal of Biological Chemistry|November 9, 2016
MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/NanogCheng-Xiong Xu, Meng Xu, Lei Tan, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2003
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North CarolinaJohnathan M Lancaster, Robert M Wenham, Susan Halabi, et al.
The Journal of Biological Chemistry|September 15, 2011
Fascin protein is critical for transforming growth factor β protein-induced invasion and filopodia formation in spindle-shaped tumor cellsJianwei Sun, Huifang He, Yin Xiong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2012
Preoperative enoxaparin is safe to use in major gynecologic surgery for prophylaxis of venous thromboembolism: a retrospective cohort studyMartin A Martino, Jennifer G George, Christine C Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2021
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody DisordersDavid Stein, Ernesto Oviedo-Orta, Wendy A Kampman, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2002
Cell proliferation and apoptosis in human uterine leiomyomas and myometriaDarlene Dixon, Gordon P Flake, Alicia B Moore, et al.
Gynecologic Oncology|December 31, 2002
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancerLaura J Havrilesky, Angeles A Alvarez, Robyn A Sayer, et al.
Annals of Surgical Oncology|January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast CancerHatem Soliman, Susanne Wagner, Darl D Flake, et al.
Gynecologic Oncology|October 24, 2007
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M Lancaster, C Bethan Powell, Noah D Kauff, et al.
Gynecologic Oncology|April 30, 2013
A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapyRobert M Wenham, James Lapolla, Hui-Yi Lin, et al.
The Journal of Biological Chemistry|November 9, 2016
MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/NanogCheng-Xiong Xu, Meng Xu, Lei Tan, et al.
Pageof 8